DVA: DaVita HealthCare Partners Inc. Stock

by  •  • Comments Off on DVA: DaVita HealthCare Partners Inc. Stock

SIC 809 – Miscellaneous Health And Allied Services, Not

Valuation
Market Cap ($M) 7,864.10
Enterprise Value ($M) 17,975.12
Book Value ($M) 2,409.08
Book Value / Share 25.47
Price / Book 3.26
NCAV ($M) -11,549.22
NCAV / Share -122.08
Price / NCAV -0.68

Profitability (mra)
Return on Invested Capital (ROIC) 0.06
Return on Assets (ROA) 0.05
Return on Equity (ROE) 0.31

Liquidity (mrq)
Quick Ratio 1.25
Current Ratio 1.29

Balance Sheet (mrq) ($M)
Current Assets 3,128.71
Assets 17,087.01
Liabilities 14,677.93
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 11,618.80
Operating Income 1,770.43
Net Income 978.45
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 1,930.88
Cash from Investing -784.73
Cash from Financing -1,082.97

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13D/A Berkshire Hathaway Inc 37.50 0.00
02-09 13G/A Vanguard Group Inc 7.34 -13.13
02-01 13G/A BlackRock Inc. 5.50 -4.79

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2022-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO
2022-02-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTI
2021-10-28 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT
2021-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO S

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2022-07-01 137,670 790,164 17.42
2022-06-30 119,060 648,361 18.36
2022-06-29 95,568 662,207 14.43
2022-06-28 268,888 1,142,298 23.54
2022-06-27 162,664 692,698 23.48

(click for more detail)

(click for list of largest short owners)

Similar Companies
AGL – agilon health, inc. CNVY – Convey Holding Parent, Inc.
CO – China Cord Blood Corp. FMS – Fresenius Medical Care AG & Co KGaA


Financial data and stock pages provided by
Fintel.io